Abstract

The article describes complex of organizational legal aspects of oncological screening for gynecological and urological diseases. These types of screening can be considered as preventive measure not only preventing development of malignant tumors of genitourinary system, but preserving male and female reproductive health, since protection of reproductive health is also preservation of public health of population.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.